Oryzon Genomics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference and at BioPharm America 2016

BARCELONA, SPAIN and CAMBRIDGE MA.

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today its CEO, Dr. Carlos Buesa, will present a corporate overview at the 18TH Annual Rodman and Renshaw Global investment Conference. The conference will take place on September 11-13, 2016, at the Palace Hotel in New York City. Dr. Buesa is scheduled to present on Tuesday, September 13th at 2:35 pm ET.

Dr. Buesa will also present a corporate overview at the 9th Annual International Partnering Conference BioPharm America-2016. The event will take place on September 13-15 in Boston, at the Marriott Copley Place Hotel. Dr. Buesa is scheduled to present on September 14th in the afternoon CNS track starting at 1.30 pm ET.

Click here to see the full Press Release